secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001438133-23-000008
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes completes acquisition of AMF Medical for CHF 70.4M upfront plus earnouts
--------------------------------------------------------------------------------

- Total upfront consideration: CHF 8.0M strategic investment (Q3 2022) plus CHF 62.4M cash at closing.
- Acquisition closed on January 19, 2023; additional contingent earnout payments may follow.
- Target: AMF Medical SA, a Swiss diabetes technology company; adds to Tandem's product portfolio.
- Transaction previously disclosed in December 2022; Purchase Agreement filed with 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000008/0001438133-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000008/tndm-20230119.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer